Open Outbreak

Hepatitis A

Also known as: HAV, hepatitis A virus

Hepatitis A is a virus that infects the liver. It usually causes an acute illness, meaning it does not become a lifelong infection. The sources retrieved in this session say it spreads mainly by the faecal-oral route: when virus from stool reaches another person through contaminated hands, food, water, or close contact. WHO also notes sexual transmission can happen, especially with oral-anal contact. Illness can be mild or have no symptoms, especially in children, but some people develop jaundice, stomach upset, fever, and marked tiredness. Severe disease is uncommon, but WHO says hepatitis A is not always mild and can occasionally be fatal. Safe and effective vaccines exist, and WHO recommends vaccination for people at increased risk and for outbreak control, including after exposure in some settings. In the documents found here, vaccine supply constraints were noted during a 2017 multi-country outbreak, which matters because quick vaccination can help limit spread.

Key facts

TransmissionMainly faecal-oral spread through contaminated hands, food, water, close contact, and some sexual contact; person-to-person spread is common.
Incubationunknown
Case fatalityRarely fatal according to WHO; a precise rate was not stated in the sources retrieved this session.
Reproduction numberunknown
VaccineYes. WHO states hepatitis A vaccine is recommended for people at increased risk and can be used for pre- and post-exposure prophylaxis; single-dose schedules may be considered during shortages.
TreatmentNo specific antiviral treatment was described in the sources retrieved this session.
Reservoirunknown
Endemic regionsEndemic worldwide, with higher endemicity in many developing countries according to a review retrieved this session.

Transmission

Hepatitis A spreads mainly when tiny amounts of infected stool get into another person’s mouth. That can happen through close personal contact, dirty hands, contaminated food, or contaminated water. A review retrieved in this session says spread is generally person to person, and less commonly through contaminated food or water. WHO adds that sexual transmission can also occur, especially through oral-anal contact. This matters because people may think of hepatitis only as a blood-borne infection, but hepatitis A is mostly a hygiene, sanitation, and close-contact infection. In places with low endemicity, WHO says outbreaks may be seen in defined higher-risk groups, including men who have sex with men, people who inject drugs, travellers to endemic areas, and some closed communities. The sources retrieved here did not provide a settled reproduction number, so how fast it spreads is best judged from the setting, sanitation, and vaccination coverage rather than a single number.

Symptoms and severity

Hepatitis A is usually an acute liver infection. WHO says it is typically self-limiting, meaning most people recover without developing chronic liver disease. The encyclopedia overview retrieved for this session says many cases, especially in younger people, have few or no symptoms. When symptoms do happen, they can include nausea, vomiting, diarrhoea, fever, abdominal pain, and jaundice, which is yellowing of the skin or eyes. WHO notes that some patients have more severe symptoms lasting for months. Severe complications are uncommon, but they do occur. The overview retrieved here says acute liver failure is rare and more common in older adults. WHO describes hepatitis A as rarely fatal, but the documents found in this session did not provide a precise case-fatality rate. For a worried reader, the key point is that most infections resolve, but illness can still be serious enough to need medical care, especially in adults or people with other liver problems.

Treatment and vaccines

The strongest tool against hepatitis A in the sources retrieved here is vaccination. WHO says countries with low endemicity should routinely offer hepatitis A vaccine to people at increased risk, including travellers to endemic areas, men who have sex with men, people who inject drugs, and people with chronic liver disease. WHO also says vaccine should be preferred for both pre-exposure and post-exposure prophylaxis, such as for close contacts of a case. During outbreaks, countries may consider a single-dose schedule when supply is limited. The 2017 WHO outbreak notice is notable because it warns that global vaccine availability was limited at that time. As for treatment, the documents found in this session did not describe a specific antiviral drug for hepatitis A. WHO instead frames control around vaccination, hygiene, food safety, and safer sex measures. That means prevention and outbreak response are the main public-health tools, while medical care is focused on monitoring and supporting the person who is ill.

Where it occurs

Hepatitis A occurs worldwide, but the pattern differs by place. The review retrieved in this session says hepatitis A is endemic in developing countries, where many people are exposed in childhood. As sanitation and hygiene improve, exposure in childhood falls. That sounds good, but it also means more adolescents and adults remain susceptible, and illness in adulthood is often more noticeable and can be more severe. WHO’s 2017 notice describes outbreaks in low-endemicity countries across the European Region and in the Americas, showing that places with generally low background rates can still have sizable outbreaks when the virus reaches groups with lower immunity. WHO also notes that food- and water-related spread remains possible, even though person-to-person spread was a major concern in that event. The sources retrieved in this session did not identify an animal reservoir, so this page does not list one. From a public-health view, hepatitis A is best thought of as a global infection whose local risk depends heavily on sanitation, immunity, travel, and vaccination coverage.

Recent history

This site’s archive summary says there has been 1 archived WHO-type event for hepatitis A since 1996, and the record listed on this site is “Hepatitis A outbreak, Costa Rica [monitoring].” In the WHO material retrieved in this session, the main recent international signal was a multi-country event published on 2017-06-07. WHO reported an unusual increase in cases mainly affecting men who have sex with men in 15 countries in the European Region, along with outbreaks in Chile and increased cases in New York City. WHO reported 1,173 outbreak-related cases in Europe as of 2017-05-16 and 706 cases in Chile as of 2017-05-05. WHO said no fatalities had been reported in connection with those outbreaks at that time. The agency also warned that the event could spread further into the wider population if vaccination, hygiene, food safety, and safer sex measures were not strengthened. So, the archive is small, but the disease has shown clear capacity for cross-border outbreaks.

What to watch

The main warning signs are practical ones. First, watch for outbreaks in new regions or in places that usually report low hepatitis A activity, because that can mean immunity gaps in the population. Second, watch for evidence of sustained person-to-person spread in settings with close contact, including sexual networks, households, shelters, or drug-use networks. Third, watch for food- or water-linked clusters, because a single contaminated source can expose many people quickly. Fourth, watch vaccine supply: WHO highlighted limited global availability during the 2017 outbreak, and shortages can make outbreak control harder. Fifth, watch whether public-health advice shifts toward broader vaccination because of increasing transmission outside recognized risk groups. The sources retrieved in this session did not describe antiviral resistance, so resistance is not a leading concern here based on the evidence available. The clearest triggers for greater concern are wider geographic spread, larger outbreaks in adults, and delayed vaccination or contact management during an outbreak.

Related outbreaks

Updated